Daymark Health spent the week reinforcing its position in value-based oncology care, highlighting both cultural and strategic developments. The company showcased a patient-centric ethos through a staff spotlight and advanced its multi-stakeholder model via new and existing partnerships.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Daymark used a LinkedIn spotlight to feature Rhode Island–based health partner Ylse Cespedes, a certified medical assistant with pediatric oncology experience at Hasbro Children’s Hospital. The company emphasized her role in supporting patients, caregivers, and families throughout the cancer journey, underscoring a strong focus on compassion, emotional support, and long-term relationships.
Cespedes described Daymark as a strong cultural and mission fit, aligning with its goal of improving the overall oncology experience. Her comments highlighted the importance of resilience and whole-journey navigation, suggesting Daymark’s model extends beyond clinical encounters to broader support and care coordination.
Strategically, Daymark advanced its value-based oncology platform by emphasizing partnerships that align payers, providers, patients, and families. The company highlighted a collaboration with Blue Cross & Blue Shield of Rhode Island and Brown University Health as a live example of its “win-win-win” approach in cancer care.
By referring to partners as co-architects, Daymark signaled that its model is co-designed with insurers and health systems, which could reduce implementation friction and support sustainability. The association with established organizations may also enhance its credibility and facilitate replication of the model in new markets and geographies.
Daymark also promoted its oncology care model at the National Healthcare Continuum Conference in Scottsdale through a Connected Care Briefing. This outreach targeted key decision-makers as value-based oncology and integrated reimbursement frameworks continue to gain momentum in the U.S. healthcare system.
On the organizational side, Daymark appointed Ryan Liefer as vice president of Provider Growth, adding experience from Oak Street Health, HCSC, Walgreens Health, Stellar Health, and Sylvan Health. His role is to scale provider partnerships nationwide and deepen engagement across the care continuum in support of Daymark’s growth strategy.
The company further strengthened its community oncology presence by hosting clinicians and cancer experts at the Community Oncology Alliance conference alongside Oncology Ventures. Discussions focused on enhancing patient support and care coordination and featured remarks from former NFL player and cancer survivor Mark Herzlich.
Collectively, the week’s developments suggest Daymark is balancing cultural investment in compassionate, patient-centered care with expansion of value-based partnerships and leadership capacity. These steps may support broader adoption of its oncology care model and reinforce its positioning within the evolving oncology ecosystem.